NeuroPace (NPCE) Consolidated Net Income (2020 - 2026)
NeuroPace (NPCE) recorded quarterly Consolidated Net Income of -$6.5 million in Q1 2026, down 139.06% quarter-over-quarter from -$2.7 million in Q4 2025, and little changed on a YoY basis from -$6.5 million in Q1 2025.
NeuroPace (NPCE) Consolidated Net Income (2020 - 2026) Analysis & Trends
NeuroPace's Consolidated Net Income history runs 7 years deep, the most recent figure standing at -$6.5 million for Q1 2026.
- In Q1 2026, Consolidated Net Income changed 0.26% year-over-year to -$6.5 million; the TTM figure through Mar 2026 stood at -$21.0 million (up 15.94% YoY), while the FY2025 annual figure was -$21.0 million, up 23.56% from the prior year.
- Consolidated Net Income was -$6.5 million for Q1 2026 at NeuroPace, down from -$2.7 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of -$2.7 million in Q4 2025 to a low of -$12.6 million in Q2 2022.
- Historically, Consolidated Net Income has averaged -$7.9 million across 5 years, with a median of -$7.6 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Consolidated Net Income tumbled 101.12% in 2022, then jumped 47.15% in 2025.
- A 5-year view of Consolidated Net Income shows it stood at -$11.0 million in 2022, then soared by 41.23% to -$6.5 million in 2023, then climbed by 20.12% to -$5.2 million in 2024, then surged by 47.15% to -$2.7 million in 2025, then sank by 139.06% to -$6.5 million in 2026.
- The last three Consolidated Net Income figures came in at -$6.5 million (Q1 2026), -$2.7 million (Q4 2025), and -$3.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | - |
| 10 | NeuroPace | 526.99 Mn | 473.01 Mn | 18.05 Mn | -6.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.52 Mn |
| Dec 31, 2025 | -2.73 Mn |
| Sep 30, 2025 | -3.58 Mn |
| Jun 30, 2025 | -8.17 Mn |
| Mar 31, 2025 | -6.51 Mn |
| Dec 31, 2024 | -5.16 Mn |
| Sep 30, 2024 | -5.67 Mn |
| Jun 30, 2024 | -7.63 Mn |
| Mar 31, 2024 | -8.98 Mn |
| Dec 31, 2023 | -6.47 Mn |
| Sep 30, 2023 | -7.37 Mn |
| Jun 30, 2023 | -9.25 Mn |
| Mar 31, 2023 | -9.56 Mn |
| Dec 31, 2022 | -11.00 Mn |
| Sep 30, 2022 | -11.68 Mn |
| Jun 30, 2022 | -12.61 Mn |
| Mar 31, 2022 | -11.46 Mn |
| Dec 31, 2021 | -10.69 Mn |
| Sep 30, 2021 | -7.93 Mn |
| Jun 30, 2021 | -6.38 Mn |